Single Cell Sequencing Market: How Is scDNA-Seq Transforming...

σε πρόσθεσε στο Health

2026-06-08 06:57:03 -

Single Cell Sequencing Market: How Is scDNA-Seq Transforming Minimal Residual Disease Monitoring?

Single-cell DNA sequencing for minimal residual disease (MRD) — the detection of residual malignant cells at 0.001% sensitivity following cancer therapy, enabling relapse prediction and treatment adaptation, representing 18% of clinical single-cell applications — creates the most commercially dynamic market segment, with the Single Cell Sequencing Market reflecting MRD monitoring as...

0 Σχόλια 0 Μοιράστηκε 474 Views 0 Προεπισκόπηση